Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

The improvement in childhood cancer treatments resulted in a marked improvement in the survival of pediatric cancer patients. However, as survival increased, it was also possible to observe the long-term side effects of cancer therapies. Among these, metabolic syndrome is one of the most frequent long-term side effects, and causes high mortality and morbidity. Consequently, it is necessary to identify strategies that allow for early diagnosis. In this review, the pathogenetic mechanisms of metabolic syndrome and the potential new biomarkers that can facilitate its diagnosis in survivors of pediatric tumors are analyzed.
Lingua originaleInglese
pagine (da-a)N/A-N/A
RivistaJournal of Personalized Medicine
Volume12
Numero di pubblicazione6
DOI
Stato di pubblicazionePubblicato - 2022

All Science Journal Classification (ASJC) codes

  • Medicina (varie)

Keywords

  • cancer survivors
  • cardiovascular disease
  • chemotherapy toxicity
  • childhood cancer
  • metabolic syndrome
  • obesity
  • radiotherapy toxicity

Fingerprint

Entra nei temi di ricerca di 'Biomarkers Predictive of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors'. Insieme formano una fingerprint unica.

Cita questo